Completed

NCT Number: NCT00208494

Metal on Metal Versus Ceramic on Metal Hip Replacement

The purpose of this study is to compare the performance of artificial hips with metal heads and metal sockets to artificial hips with ceramic heads articulating with metal socket components. The success of the total hip arthroplasty (THA) will be based upon all of the following clinical and radiographic criteria being met at the two-year evaluation: (1) the patient's clinical results as measured using modified Harris Hip evaluation rating system, and the absence of a complication that requires the surgical removal or replacement of a component; and (2) radiographic findings at study endpoint (i.e., two years follow-up). Clinical and radiographic success at two (2) years postoperative is required for the study hip to be deemed successful.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non-inflammatory Joint Diseases

Age range

20 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

London, Ontario, Canada

About this study

This study is a prospective, multi-center, randomized, single blind, controlled clinical investigation comparing the safety and efficacy of the cementless Ceramic on Metal total hip prostheses versus the cementless Metal on Metal total hip prostheses.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Able to (or capable of) provide consent to participate in the clinical investigation prior to the day of the surgery.
Skeletally mature (tibial and femoral epiphyses are closed)
Undergoing cementless primary hip replacement surgery for Noninflammatory Degenerative Joint Disease
Affected hip has a Harris Hip Score of 70 or lower and a Pain rating of Moderate or greater
Radiographic Parameters:
X-Ray Evaluation confirms the presence of NIDJD
Femoral and acetabular bone stock is sufficient, regarding strength and shape, and is suitable to receive the implants
No structural bone grafts required to support to prosthetic component(s)or to shape the bone to receive implant(s)
Willing to have knowledge of treatment arm (CoM or MoM) withheld for a period of 24 months post-operatively unless disclosure is legally and/or medically necessary
Previous THA in contralateral hip that is greater than one (1) year postoperative and has a Harris Hip pain rating less than MILD

Exclusion criteria

Bilateral hip disease with the anticipated need for bilateral hip implant during study participation (i.e., within the next 24 months)
THA required for the revision of a previously failed THA
Suffering from inflammatory arthritis
Prior prosthetic hip replacement
Previous Girdlestone procedure or surgical fusion in the operative hip joint
Above knee amputation of either the contralateral or ipsilateral leg
Known allergy to metal (e.g. jewelry)
The presence of highly communicable disease or diseases that may limit follow-up (e.g., immuno-compromised conditions, hepatitis, active tuberculosis, etc.)
Significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g., muscular dystrophy, multiple sclerosis)
Conditions that may interfere with the total hip arthroplasty survival or outcome (e.g., Paget's disease, Charcot's disease)
Unwilling or unable to comply with a rehabilitation program for a cementless THA or difficulty or inability to return for follow-up visits prescribed by the study protocol
Known to be pregnant, a prisoner, mentally incompetent, and/or alcohol or drug abuser
Previous treatment for renal disease
Any systemic steroid therapy, excluding inhalers, within three months prior to surgery

Treatment and study plan

Total Hip Replacement

Device

Total hip replacement

Other names: Biolox Delta head; Ultamet insert; Pinnacle Acetabular shell

Primary outcomes

Composite Success/Failure

Time frame: At 24 months

The composite success/failure of the implant was made up of radiographic, clinical and revision data. Radiographic success was determined by femoral subsidence =/< 2mm, acetabular migration =/< 2mm, cup inclination =/< 4°, no acetabular or femoral osteolysis, and acetabular and femoral lucencies less than 50% of visible porous coating. Clinical success was determined by a Harris Hip score equal to or greater than 80. A hip (patient) was considered to be a composite success at study endpoint if it was a radiographic and clinical success and no revision of any component had taken place.

Sponsors and collaborators

Lead sponsor

DePuy Orthopaedics

Industry

Registry information

Official study title

Comparative Study to Evaluate the Safety and Efficacy of the DePuy Ceramic-on-metal Total Hip Prosthesis Versus the DePuy Metal-on-metal Total Hip Prosthesis Through Clinical and Radiographical Data

Important dates

Study start: 2005
Primary completion: 2008
Study completion: 2011
First posted: Sep 21, 2005
Registry last updated: Aug 14, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.